Placebo Response is Driven by UCS Revaluation: Evidence, Neurophysiological Consequences and a Quantitative Model

TL;DR

This paper presents a neurophysiological model of the placebo response driven by UCS revaluation learning, highlighting neural mechanisms and proposing a new approach to enhance drug effectiveness.

Contribution

It introduces a theoretical model linking UCS revaluation to placebo response, with a formal proof of neural coding of expected and reactive responses.

Findings

Placebo response involves neural revaluation mechanisms.

Reactive responses are updated via implicit learning.

The model suggests new neuropharmacological treatment strategies.

Abstract

Despite growing scientific interest in the placebo effect and increasing understanding of neurobiological mechanisms, theoretical modeling of the placebo response remains poorly developed. The most extensively accepted theories are expectation and conditioning, involving both conscious and unconscious information processing. However, it is not completely understood how these mechanisms can shape the placebo response. We focus here on neural processes which can account for key properties of the response to substance intake. It is shown that placebo response can be conceptualized as a reaction of a distributed neural system within the central nervous system. Such a reaction represents an integrated component of the response to open substance administration (or to substance intake) and is updated through "unconditioned stimulus (UCS) revaluation" learning. The analysis leads to a theorem, which proves the existence of two distinct quantities coded within the brain, these are the expected or prediction outcome and the reactive response. We show that the reactive response is updated automatically by implicit revaluation lerning, while the expected outcome can also be modulated through conscious information processing. Conceptualizing the response to substance intake in terms of UCS revaluation learning leads to the theoretical formulation of a potential neuropharmacological treatment for increasing unlimitedly the effectiveness of a given drug.